Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era – a report from the Swedish CML register期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era – a report from the Swedish CML register

Authors:	Stina Söderlund Torsten Dahlén Fredrik Sandin Ulla Olsson‐Strömberg Maria Creignou Arta Dreimane Anna Lübking Berit Markevärn Anders Själander Hans Wadenvik Leif Stenke Johan Richter Martin Höglund

Affiliation:	1. Department of Medical Sciences, Uppsala University, Uppsala, Sweden;2. Section of Haematology, Uppsala University Hospital, Uppsala, Sweden;3. Department of Haematology, Karolinska University Hospital, Stockholm, Sweden;4. Department of Medicine, Karolinska Institutet, Stockholm, Sweden;5. Regional Cancer Centre Uppsala‐?rebro, Uppsala, Sweden;6. Department of Haematology, Link?ping University Hospital, Link?ping, Sweden;7. Department of Haematology, Oncology and Radiation Physics, Sk?ne University Hospital, Lund, Sweden;8. Department of Haematology, Ume? University Hospital, Ume?, Sweden;9. Department of Public Health and Clinical Medicine, Ume? University, Ume?, Sweden;10. Section of Haematology and Coagulation, Sahlgrenska University Hospital, G?teborg, Sweden

Abstract:

Keywords:	chronic myeloid leukaemia accelerated phase blast crisis tyrosine kinase inhibitor population‐based